What is the CVR number of Mortek Danmark ApS?

Mortek Danmark ApS is registered with CVR / Virk under CVR 42791237.

What is the revenue of Mortek Danmark ApS?

Mortek Danmark ApS reported revenue of DKK 415K in 2024.

Who is the CEO of Mortek Danmark ApS?

Erik Sejersen is Management of Mortek Danmark ApS, in role since 2023.

Where is Mortek Danmark ApS headquartered?

Mortek Danmark ApS's registered address is Ved Skoven 35.

Mortek Danmark ApS

APSActive

CVR 42791237Ved Skoven 35Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2021— employees

Full Risika report

Revenue 2024

DKK 415K

-10% vs 2023

EBITDA margin

100.0%

-10% vs 2023

Equity ratio

77.5%

Financial strength

Net profit 2024

DKK 323K

-13% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 415K	-10%
EBITDA	DKK 415K	-10%
Net profit	DKK 323K	-13%
Total assets	DKK 1,8M	+32%
Equity	DKK 1,4M	+30%
Employees	—	—

Item	2021	2022	2023	2024
Revenue	—	—	462	415
Staff expenses	-0	-0	-0	-0
EBITDA	494	1.476	462	415
Depreciation & amort.	-0	-0	-0	-0
EBIT	494	1.476	462	415
Net financials	-3	-12	15	-0
Profit before tax	491	1.459	477	414
Tax	114	335	105	92
Net profit	377	1.123	372	323

Item	2021	2022	2023	2024
Total assets	788	2.181	1.368	1.800
Equity	417	700	1.072	1.395
Long-term debt	0	0	0	0
Short-term debt	371	1.481	295	404
Total debt	371	1.481	295	404

Name	Role	Member since	Age	Other directorships
ES Erik Sejersen Management	Management	2023	—	—
HS Henriette Skjødt Chief Executive Officer	Chief Executive Officer	2023	—	—
MT Morten Teilstad Management	Management	2021	—	—
MA Mortek AS Founder	Founder	2021	—	—

Shareholder	Type	Ownership	Votes	Since
DATEC MEDICO ApS	Company	100.0%	100.0%	2023
JOPS Invest ApS	Company	100.0%	100.0%	2022

Person	Role here	Other companies
Erik Sejersen	Management	0 companies
Henriette Skjødt	Chief Executive Officer	0 companies
Morten Teilstad	Management	0 companies
Mortek AS	Founder	0 companies

Mortek Danmark ApS

APSActive

CVR 42791237Ved Skoven 35Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2021— employees

Full Risika report

Revenue 2024

DKK 415K

-10% vs 2023

EBITDA margin

100.0%

-10% vs 2023

Equity ratio

77.5%

Financial strength

Net profit 2024

DKK 323K

-13% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 415K	-10%
EBITDA	DKK 415K	-10%
Net profit	DKK 323K	-13%
Total assets	DKK 1,8M	+32%
Equity	DKK 1,4M	+30%
Employees	—	—